New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management.
Alessandra CuomoFrancesca PaudiceGiovanni D'AngeloGiovanni PerrottaAntonio CarannanteUmberto AttanasioMartina IengoFrancesco FioreCarlo Gabriele TocchettiValentina MercurioFlora PirozziPublished in: Current heart failure reports (2021)
Novel findings suggest that HF and cancer, beside common risk factors, are deeply linked by shared pathophysiological mechanisms. In particular, HF itself may enhance carcinogenesis by producing pro-inflammatory cytokines, and it has been suggested that neurohormonal activation, commonly associated with the failing heart, might play a pivotal role in promoting neoplastic transformation. The risk of malignancies seems to be higher in HF patients compared to the general population, probably due to shared risk factors and common pathophysiological pathways. Additionally, management of these patients represents a challenge for clinicians, considering that the co-existence of these diseases significantly worsens patients' prognosis and negatively affects therapeutic options for both diseases.